#54: Current state of surgical revascularization in patients with CAD with Dr Timothy Gardner

This feature requires the newest version of Flash. You can download it here.

The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have learned from FREEDOM, BARI, BARI 2D, and PREVENT, ad hoc PCI, the role of the heart team, and why collaboration between interventionalist and CV surgeon is the way of the future.

	Timothy Gardner MD Professor, Thomas Jefferson University Medical Director, Center for Heart and Vascular Executive Director, Value Institute Christiana Care Health System Newark, DE
	Robert Harrington MD Arthur L Bloomfield Professor of Medicine and Chair Department of Medicine Stanford University Stanford, CA

Dr Gardner has served as the steering committee chair for the Cardiothoracic Clinical Research Network.

For Dr Harrington's disclosures, click here.

See also:

• SCAI releases new consensus on "ad hoc" PCI

• FREEDOM: CABG superior to PCI in diabetic patients with coronary disease

• No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D

Cite this: #54: Current state of surgical revascularization in patients with CAD with Dr Timothy Gardner - Medscape - Jan 08, 2013.